There have been no open-market insider trades at IGM Biosciences, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at IGM Biosciences, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Tahir Misbah | CFO | Sell | 8,741 | $1.27 | $11K | SEC |
| Jul 25, 2025 | Harler Mary Beth | CEO | Sell | 14,501 | $1.27 | $18K | SEC |
| Jul 25, 2025 | Decker Lisa Lynn | Executive Officer | Sell | 4,409 | $1.27 | $6K | SEC |
| Jun 20, 2025 | Weber Steven | Officer | Sell | 486 | $1.20 | $583 | SEC |
| Jun 20, 2025 | Tahir Misbah | CFO | Sell | 1,522 | $1.20 | $2K | SEC |
| Jun 20, 2025 | Harler Mary Beth | CEO | Sell | 1,522 | $1.20 | $2K | SEC |
| Jun 20, 2025 | Decker Lisa Lynn | Executive Officer | Sell | 951 | $1.20 | $1K | SEC |
| May 16, 2025 | Weber Steven | Officer | Sell | 1,865 | $1.12 | $2K | SEC |
| Mar 18, 2025 | Weber Steven | Officer | Sell | 1,701 | $1.23 | $2K | SEC |
| Mar 18, 2025 | Tahir Misbah | CFO | Sell | 7,329 | $1.23 | $9K | SEC |
| Mar 18, 2025 | Harler Mary Beth | CEO | Sell | 7,329 | $1.23 | $9K | SEC |
| Mar 18, 2025 | Decker Lisa Lynn | Executive Officer | Sell | 4,512 | $1.23 | $6K | SEC |
| Jan 17, 2025 | Weber Steven | Officer | Sell | 1,122 | $1.70 | $2K | SEC |
| Dec 18, 2024 | Weber Steven | Officer | Sell | 539 | $7.48 | $4K | SEC |
| Dec 18, 2024 | Tahir Misbah | CFO | Sell | 1,708 | $7.48 | $13K | SEC |
There were no open-market insider trades in IGMS in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in IGMS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).